The LAMEA dermal fillers market is estimated to grow at a CAGR of 7.4% during the forecast period. RoW countries include Brazil, Mexico and Colombia, Saudi Arabia and the United Arab Emirates (UAE). RoW dermal fillers market is estimated to grow significantly during the forecast period owing to the rising demand for non-surgical procedures coupled with the rising availability of filler options available in the Brazilian market. As a result, the companies are looking to expand the availability of their dermal fillers in these countries. For instance, in January 2018, Sinclair Pharma plc announced that it has received regulatory approval of Ellansé by ANVISA in Brazil. Brazil is considered as one of the major aesthetic dermatology markets with a considerable rise in the injectable procedures reported in 2017.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/lamea-dermal-fillers-market
This is representing a significant demand for non-surgical cosmetic procedures in these countries. For instance, as per ISAPS, in Brazil, the number of injectable procedures was 677,765 in 2017, whereas, in Columbia, it was 125,350 in 2017. Due to such a rise in injectable procedures, a significant availability of plastic surgeons has been witnessed in 2017. For instance, as per the ISAPS, in 2017, the estimated number of plastic surgeons in Brazil was 5,500, while, the estimated number of plastic surgeons in Colombia was 1,000. The demand for this injectable procedure is anticipated to grow significantly in the region coupled with increasing disposable income across the countries, such as Saudi Arabia and UAE, which in turn, will likely drive the demand for dermal filler treatment in the region.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/lamea-dermal-fillers-market
The LAMEA dermal fillers market can be segmented based on application, type, and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
Market Segmentation
By Application
- Face-Lift
- Lip Treatment/Enhancement
- Facial Line Correction Treatment
- Others (Acne Scar Treatment)
By Type
- Collagen Fillers
- Ploy-L-Lactic Acid (PLLA)
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
By End-User
- Dermatology Clinics
- Hospitals
REGIONAL ANALYSIS
- Brazil
- Argentina
- UAE
- South Africa
- Nigeria
- Rest of LAMEA
COMPANY PROFILES
- Allergan PLC
- Anika Therapeutics, Inc.
- Croma-Pharma GmbH
- Cynosure LLC
- Galderma Laboratories, L.P.
- Huons Co. Ltd.
- Merz Pharmaceuticals GmbH
- Prollenium Medical Technologies, Inc.
- Sculpt Luxury Dermal Fillers Ltd.
- Suneva Medical, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
